The 5-HT2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines

Placenta

Volumn 31, Issue 5, 2010, Pages 439-447

  Oufkir, T ^a   Arseneault, M ^a   Sanderson, J T ^a   Vaillancourt, C ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

5 HT receptor; BeWo; Cell cycle; Cell proliferation; JAK STAT; JEG 3; MAPK; Placenta; Serotonin

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; JANUS KINASE 2; KETANSERIN; MITOGEN ACTIVATED PROTEIN KINASE 1; SEROTONIN; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; STAT3 PROTEIN;

ARTICLE; BEWO CELL; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL INVASION; CELL LINE; CELL MIGRATION; CELL STRAIN JEG 3; CELL SURVIVAL; CELL VIABILITY; CHORIOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; PREMATURITY; PRIORITY JOURNAL; REPRODUCTION; SIGNAL TRANSDUCTION; TROPHOBLAST; WESTERN BLOTTING;

ADULT; AMPHETAMINES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHORIOCARCINOMA; CHORIONIC VILLI; ENZYME ACTIVATION; FEMALE; HUMANS; JANUS KINASE 2; MAP KINASE SIGNALING SYSTEM; PREGNANCY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS; STAT3 TRANSCRIPTION FACTOR; TROPHOBLASTS;

EID: 77951978885     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.02.019     Document Type: Article

References (45)

1. Jonnakuty C., and Gragnoli C. What do we know about serotonin?. J Cell Physiol 217 (2008) 301-306
2. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21 (1999) 33S-45S
3. Buznikov G.A., Lambert H.W., and Lauder J.M. Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Res 305 (2001) 177-186
4. Cote F., Fligny C., Bayard E., Launay J.M., Gershon M.D., Mallet J., et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA 104 (2007) 329-334
5. Bolte A.C., van Geijn H.P., and Dekker G.A. Pathophysiology of preeclampsia and the role of serotonin. Eur J Obstet Gynecol Reprod Biol 95 (2001) 12-21
6. Radenkovic M., Radunovic N., Momcilov P., and Grbovic L. Altered response of human umbilical artery to 5-HT in gestational diabetic pregnancy. Pharmacol Rep 61 (2009) 520-528
7. Sonier B., Lavigne C., Arseneault M., Ouellette R., and Vaillancourt C. Expression of the 5-HT2A serotoninergic receptor in human placenta and choriocarcinoma cells: mitogenic implications of serotonin. Placenta 26 (2005) 484-490
8. Viau M., Lafond J., and Vaillancourt C. Expression of placental serotonin transporter and 5-HT2A receptor in normal and gestational diabetes mellitus pregnancies. Reprod Biomed Online 19 (2009) 207-215
9. Huang W.Q., Zhang C.L., Di X.Y., and Zhang R.Q. Studies on the localization of 5-hydroxytryptamine and its receptors in human placenta. Placenta 19 (1998) 655-661
10. Bottalico B., Larsson I., Brodszki J., Hernandez-Andrade E., Casslen B., Marsal K., et al. Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 25 (2004) 518-529
11. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 (2002) 533-554
12. Nebigil C.G., Garnovskaya M.N., Spurney R.F., and Raymond J.R. Identification of a rat glomerular mesangial cell mitogenic 5-HT2A receptor. Am J Physiol 268 1 Pt 2 (1995) F122-F127
13. Guillet-Deniau I., Burnol A.F., and Girard J. Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway. J Biol Chem 272 (1997) 14825-14829
14. Banes A.K.L., Shaw S.M., Tawfik A., Patel B.P., Ogbi S., Fulton D., et al. Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol 288 (2005) C805-C812
15. Azmitia E.C. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56 (2001) 413-424
16. Watts S.W., Yang P., Banes A.K., and Baez M. Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol 38 (2001) 539-551
17. Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal 13 (2001) 777-785
18. Imada K., and Leonard W.J. The Jak-STAT pathway. Mol Immunol 37 (2000) 1-11
19. Forbes K., Westwood M., Baker P.N., and Aplin J.D. Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am J Physiol 294 (2008) C1313-C1322
20. Marino V.J., and Roguin L.P. The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line. J Cell Biochem 103 (2008) 1512-1523
21. Daoud G., Amyot M., Rassart E., Masse A., Simoneau L., and Lafond J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol 566 (2005) 409-423
22. Vaillancourt C., Lanoix D., Le Bellego F., Daoud G., and Lafond J. Involvement of MAPK signalling in human villous trophoblast differentiation. Mini Rev Med Chem 9 (2009) 962-973
23. Poehlmann T.G., Fitzgerald J.S., Meissner A., Wengenmayer T., Schleussner E., Friedrich K., et al. Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta 26 Suppl. A (2005) S37-S41
24. Corvinus F.M., Fitzgerald J.S., Friedrich K., and Markert U.R. Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am J Reprod Immunol 50 (2003) 316-321
25. Chakraborty C., Gleeson L.M., McKinnon T., and Lala P.K. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 80 (2002) 116-124
26. Prast J., Saleh L., Husslein H., Sonderegger S., Helmer H., and Knofler M. Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology 149 (2008) 979-987
27. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 213 (2007) 589-602
28. Naor Z., Benard O., and Seger R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11 (2000) 91-99
29. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92 (2001) 179-212
30. Greene E.L., Houghton O., Collinsworth G., Garnovskaya M.N., Nagai T., Sajjad T., et al. 5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells. Am J Physiol Renal Physiol 278 (2000) F650-F658
31. Grewal J.S., Mukhin Y.V., Garnovskaya M.N., Raymond J.R., and Greene E.L. Serotonin 5-HT2A receptor induces TGF-beta1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am J Physiol 276 (1999) F922-F930
32. Watts S.W. Activation of the mitogen-activated protein kinase pathway via the 5-HT2A receptor. Ann N Y Acad Sci 861 (1998) 162-168
33. Sonier B., Arseneault M., Lavigne C., Ouellette R.J., and Vaillancourt C. The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun 343 (2006) 1053-1059
34. Mounier C., Barbeau B., Vaillancourt C., and Lafond J. Endocrinology and cell signaling in human villous trophoblast. Methods Mol Biol 550 (2009) 89-102
35. Bilban M., Barth S., Cervar M., Mauschitz R., Schaur R.J., Zivkovic F., et al. Differential regulation of endothelin secretion and endothelin receptor mRNA levels in JAR, JEG-3, and BeWo choriocarcinoma cell lines and in human trophoblasts, their nonmalignant counterpart. Arch Biochem Biophys 382 (2000) 245-252
36. Hohn H.P., Linke M., Ugele B., and Denker H.W. Differentiation markers and invasiveness: discordant regulation in normal trophoblast and choriocarcinoma cells. Exp Cell Res 244 (1998) 249-258
37. Quinn J.C., Johnson-Farley N.N., Yoon J., and Cowen D.S. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J Pharmacol Exp Ther 303 (2002) 746-752
38. Banes A., Florian J.A., and Watts S.W. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 291 (1999) 1179-1187
39. Thompson B.R., Mazurkiewicz-Munoz A.M., Suttles J., Carter-Su C., and Bernlohr D.A. Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling. J Biol Chem 284 (2009) 13473-13480
40. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 109 (2002) 1139-1142
41. Yu H., Kortylewski M., and Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7 (2007) 41-51
42. Bowman T., Garcia R., Turkson J., and Jove R. STATs in oncogenesis. Oncogene 19 (2000) 2474-2488
43. Bolte A.C., van Eyck J., Gaffar S.F., van Geijn H.P., and Dekker G.A. Ketanserin for the treatment of preeclampsia. J Perinat Med 29 (2001) 14-22
44. Weiner C.P., Socol M.L., and Vaisrub N. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist. Am J Obstet Gynecol 149 (1984) 496-500
45. Regnault T.R.H., Galan H.L., Parker T.A., and Anthony R.V. Placental development in normal and compromised pregnancies - a review. Placenta 23 (2002) S119-S129